case_images: PMC3654714_01
case_images: Multiple peritoneal metastases after surgery were confirmed by a PET-CT whole-body scan in February 2011 (A). The irregular speculated soft tissue mass in the proximal superior mesenteric artery lesion (20 mm; (a)) and the right side mesentery mass (32 mm; (b)) disappeared in the recent CT scans ((a') and (b')) after only aRVS treatment. All the metastases disappeared in the recent PET-CT scans in February 2012 after only aRVS treatment (B).
case_images: ECAM2013-203168.001.jpg
case_images: PMC3654714_01_ECAM2013-203168.001.jpg
case_images: fig1
case_images: PPPD site. PET-CT whole body scans confirmed multiple peritoneal metastases (Figure 1(A)). Recent PET-CT scans in February 2012 revealed complete disappearance of her AAV (Figure 1(B)).
case_images: PMC3654714_02
case_images: An abdominal CT scan in August 2010 revealed a mass in the ampulla of Vater legion ((A) & (B)). After only aRVS treatment, a recent abdominal CT scan in July 2011 showed that no definite mass is seen in the region of the ampulla of Vater nor is there any definite evidence for metastatic mass ((A') and (B')).
case_images: ECAM2013-203168.002.jpg
case_images: PMC3654714_02_ECAM2013-203168.002.jpg
case_images: fig2
case_images: Follow-up CT scans in July 2011 showed no evidence of tumor recurrence (Figure 2).
case_images: PMC3654714_03
case_images: An abdominal CT scan in July 2010 revealed a necrotic metastatic lesion in the right lobe of liver and a metastatic mass in mesentery LUQ ((A) & (B)). After only aRVS treatment, a recent abdominal CT scan in March 2012 showed slight increase in size of metastatic masses over 20 months ((A') and (B')).
case_images: ECAM2013-203168.003.jpg
case_images: PMC3654714_03_ECAM2013-203168.003.jpg
case_images: fig3
case_images: She has received aRVS treatment as alternative therapy since July 2010 (Figures 3(A) and 3(B)). The recent CT scans in March 2012 showed no significant change, indicating stable disease compared to the CT scans in June 2011 (Figures 3(A') and 3(B')).